LCAT and kidney disorder: Our findings also reinforce the concept that multiple biochemical alterations associated with reduced LCAT function may be involved in the pathogenesis of renal damage and its progression: UC, TC, non-HDL-C, and LDL-C seems to be potential prognostic mediators of renal disease severity or progression, thus providing rationale for their therapeutic management with existing lipid-lowering therapies.